The Optimization of HAART for Chinese--a RCT Study
Latest Information Update: 25 Aug 2020
At a glance
- Drugs Efavirenz/lamivudine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 16 Feb 2020 Status changed from active, no longer recruiting to completed.
- 15 Jul 2018 Planned primary completion date changed from 30 Jun 2019 to 10 Jul 2019.
- 15 Jul 2018 Status changed from recruiting to active, no longer recruiting.